Works matching IS 21938245 AND DT 2025 AND VI 14 AND IP 4


Results: 13
    1
    2

    The Impact of Disease Activity Criteria on Extending Injection Intervals in Real-World Patients with Neovascular Age-Related Macular Degeneration.

    Published in:
    Ophthalmology & Therapy, 2025, v. 14, n. 4, p. 773, doi. 10.1007/s40123-025-01108-z
    By:
    • Bhatia, Bhairavi;
    • Sim, Sing Yue;
    • Chalkiadaki, Evangelia;
    • Koutsocheras, Georgios;
    • Nicholson, Luke;
    • Selvam, Senthil;
    • Sivaprasad, Sobha;
    • Pal, Bishwanath;
    • Huemer, Josef;
    • Keane, Pearse A.;
    • Hamilton, Robin;
    • Patel, Praveen J.;
    • Logeswaran, Abison;
    • Tufail, Adnan;
    • Gurbaxani, Avinash;
    • Egan, Catherine;
    • Bessant, David;
    • Thomas, Dhanes;
    • Ling, Heng;
    • Basheer, Khadijah
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10

    Performance and Safety of a Sodium Hyaluronate, Xanthan Gum, and Osmoprotectants Ophthalmic Solution in the Treatment of Dry Eye Disease: An Observational Clinical Investigation.

    Published in:
    Ophthalmology & Therapy, 2025, v. 14, n. 4, p. 675, doi. 10.1007/s40123-025-01099-x
    By:
    • Molero Senosiaín, Mercedes;
    • Burgos-Blasco, Barbara;
    • Perez-García, Pilar;
    • Sánchez-Ventosa, Álvaro;
    • Villalba-González, Marta;
    • López Pérez, María Dolores;
    • Díaz, José Carlos;
    • Díaz-Mesa, Vanesa;
    • Villarrubia Cuadrado, Alberto;
    • Artiaga Elordi, Enrique;
    • Larrosa Poves, Jose Manuel;
    • Blasco, Alejandro;
    • Mateo, Antonio;
    • Civiale, Claudine;
    • Bonino, Laura;
    • Cano-Ortiz, Antonio
    Publication type:
    Article
    11
    12
    13